Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nautilus Biotechnology (NAUT) Interest Expenses (2022 - 2026)

Nautilus Biotechnology has reported Interest Expenses over the past 5 years, most recently at $15000.0 for Q1 2026.

  • Quarterly results put Interest Expenses at $15000.0 for Q1 2026, changed N/A from a year ago — trailing twelve months through Mar 2026 was $47000.0 (down 44.05% YoY), and the annual figure for FY2025 was $32000.0, down 61.9%.
  • Interest Expenses reached $15000.0 in Q1 2026 per NAUT's latest filing, up from $11000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $56000.0 in Q4 2023 and bottomed at $3000.0 in Q1 2023.
  • Median Interest Expenses over the past 5 years was $15000.0 (2026), compared with a mean of $19000.0.
  • The largest annual shift saw Interest Expenses surged 35.71% in 2024 before it crashed 75.56% in 2025.
  • Over 5 years, Interest Expenses stood at $5000.0 in 2022, then skyrocketed by 1020.0% to $56000.0 in 2023, then fell by 19.64% to $45000.0 in 2024, then plummeted by 75.56% to $11000.0 in 2025, then skyrocketed by 36.36% to $15000.0 in 2026.
  • Business Quant data shows Interest Expenses for NAUT at $15000.0 in Q1 2026, $11000.0 in Q4 2025, and $5000.0 in Q3 2025.